Heparin News and Research

RSS
Heparin, a highly-sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machines. Pharmaceutical grade heparin is derived from mucosal tissues of slaughtered meat animals such as porcine (pig) intestine or bovine (cow) lung.
Study suggests algal polysaccharide may be a promising anti-COVID-19 candidate

Study suggests algal polysaccharide may be a promising anti-COVID-19 candidate

Thrombosis with thrombocytopenia syndrome rare but serious adverse event associated with Ad26.COV2.S vaccination

Thrombosis with thrombocytopenia syndrome rare but serious adverse event associated with Ad26.COV2.S vaccination

Anti-platelet drug class fails to extend survival in moderately ill COVID-19 patients

Anti-platelet drug class fails to extend survival in moderately ill COVID-19 patients

COVID-19 drug candidate with wide-ranging antiviral activity

COVID-19 drug candidate with wide-ranging antiviral activity

Automated method shows predictive power for COVID-19 in-hospital mortality

Automated method shows predictive power for COVID-19 in-hospital mortality

Therapeutic heparin for preventing COVID-19 deaths is four times higher than the prophylactic dose

Therapeutic heparin for preventing COVID-19 deaths is four times higher than the prophylactic dose

Suggested mechanism of SARS-CoV-2 infection inhibition by Mitoxantrone

Suggested mechanism of SARS-CoV-2 infection inhibition by Mitoxantrone

SARS-CoV-2 immune responses in nursing home residents after full vaccination with Pfizer-BioNTech COVID-19 vaccine

SARS-CoV-2 immune responses in nursing home residents after full vaccination with Pfizer-BioNTech COVID-19 vaccine

Characterization of circulating neutrophils from hospitalized COVID-19 patients

Characterization of circulating neutrophils from hospitalized COVID-19 patients

Study outlines a baseline bundle of care interventions for critically ill patients

Study outlines a baseline bundle of care interventions for critically ill patients

Could monitoring headaches after COVID-19 vaccination help identify rare cases of cerebral venous thrombosis?

Could monitoring headaches after COVID-19 vaccination help identify rare cases of cerebral venous thrombosis?

Evolved SARS-CoV-2 viruses gain higher infectivity and cause more rapid infection spread

Evolved SARS-CoV-2 viruses gain higher infectivity and cause more rapid infection spread

Researchers focus on improving biomaterials used for bone and tissue repair

Researchers focus on improving biomaterials used for bone and tissue repair

Assessing the risks of thrombotic events post vaccination with ChAdOx1 and BNT162b2 vaccines in England

Assessing the risks of thrombotic events post vaccination with ChAdOx1 and BNT162b2 vaccines in England

Persistence of Anti-PF4 levels in VITT patients four months after AstraZeneca COVID-19 vaccine

Persistence of Anti-PF4 levels in VITT patients four months after AstraZeneca COVID-19 vaccine

Therapeutic-dose anticoagulation benefits moderately ill COVID-19 patients

Therapeutic-dose anticoagulation benefits moderately ill COVID-19 patients

New biocompatible glue could quickly seal injured tissues and stop bleeding

New biocompatible glue could quickly seal injured tissues and stop bleeding

Full dose anticoagulation with heparin improves outcomes for moderately ill COVID-19 patients

Full dose anticoagulation with heparin improves outcomes for moderately ill COVID-19 patients

Initiating therapeutic anticoagulation benefits moderately ill COVID-19 patients, but not critically ill patients

Initiating therapeutic anticoagulation benefits moderately ill COVID-19 patients, but not critically ill patients

Full intensity heparin has value in treating hospitalized COVID-19 patients

Full intensity heparin has value in treating hospitalized COVID-19 patients